Peter Barton Hutt

Peter Barton Hutt has an estimated net worth of $8.18 Million. This is based on reported shares across multiple companies, which include Moderna, Inc., IMMUNOMEDICS INC, BIND Therapeutics, Inc, Q Holdings, Inc., Celera CORP, XOMA LTD /DE/, Seres Therapeutics, Inc., CONCERT PHARMACEUTICALS, INC., SELECTA BIOSCIENCES INC, Flex Pharma, Inc., MOMENTA PHARMACEUTICALS INC, ISTA PHARMACEUTICALS INC, Phase Forward Inc, MMR Information Systems, Inc., INTROGEN THERAPEUTICS INC, QUICK MED TECHNOLOGIES INC, and CV THERAPEUTICS INC.

2006 was Peter Barton Hutt's most active year for acquiring shares with 9 total transactions. Peter Barton Hutt's most active month to acquire stocks was the month of May. 2012 was Peter Barton Hutt's most active year for disposing of shares, totalling 11 transactions. Peter Barton Hutt's most active month to dispose stocks was the month of May. 2015 saw Peter Barton Hutt paying a total of $249,998.94 for 113,746 shares, this is the most they've acquired in one year. In 2019 Peter Barton Hutt cashed out on 607,078 shares for a total of $5,835,487.09, their largest year based on trade value.